These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 15223333

  • 1. Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development.
    Cowan CA, Yokoyama N, Saxena A, Chumley MJ, Silvany RE, Baker LA, Srivastava D, Henkemeyer M.
    Dev Biol; 2004 Jul 15; 271(2):263-71. PubMed ID: 15223333
    [Abstract] [Full Text] [Related]

  • 2. Distinct roles of ephrin-B2 forward and EphB4 reverse signaling in endothelial cells.
    Hamada K, Oike Y, Ito Y, Maekawa H, Miyata K, Shimomura T, Suda T.
    Arterioscler Thromb Vasc Biol; 2003 Feb 01; 23(2):190-7. PubMed ID: 12588758
    [Abstract] [Full Text] [Related]

  • 3. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.
    Noren NK, Lu M, Freeman AL, Koolpe M, Pasquale EB.
    Proc Natl Acad Sci U S A; 2004 Apr 13; 101(15):5583-8. PubMed ID: 15067119
    [Abstract] [Full Text] [Related]

  • 4. Regulation of signaling interactions and receptor endocytosis in growing blood vessels.
    Pitulescu ME, Adams RH.
    Cell Adh Migr; 2014 Apr 13; 8(4):366-77. PubMed ID: 25482636
    [Abstract] [Full Text] [Related]

  • 5. Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation.
    Bai J, Wang YJ, Liu L, Zhao YL.
    J Int Med Res; 2014 Apr 13; 42(2):405-15. PubMed ID: 24517927
    [Abstract] [Full Text] [Related]

  • 6. Bidirectional signaling mediated by ephrin-B2 and EphB2 controls urorectal development.
    Dravis C, Yokoyama N, Chumley MJ, Cowan CA, Silvany RE, Shay J, Baker LA, Henkemeyer M.
    Dev Biol; 2004 Jul 15; 271(2):272-90. PubMed ID: 15223334
    [Abstract] [Full Text] [Related]

  • 7. Divergent Roles of Ephrin-B2/EphB4 Guidance System in Pulmonary Hypertension.
    Crnkovic S, Rittchen S, Jandl K, Gindlhuber J, Zabini D, Mutgan AC, Valzano F, Boehm PM, Hoetzenecker K, Toller W, Veith C, Heinemann A, Schermuly RT, Olschewski A, Marsh LM, Kwapiszewska G.
    Hypertension; 2023 Feb 15; 80(2):e17-e28. PubMed ID: 36519465
    [Abstract] [Full Text] [Related]

  • 8. The receptor tyrosine kinase EphB4 and ephrin-B ligands restrict angiogenic growth of embryonic veins in Xenopus laevis.
    Helbling PM, Saulnier DM, Brändli AW.
    Development; 2000 Jan 15; 127(2):269-78. PubMed ID: 10603345
    [Abstract] [Full Text] [Related]

  • 9. Neural crest defects in ephrin-B2 mutant mice are non-autonomous and originate from defects in the vasculature.
    Lewis AE, Hwa J, Wang R, Soriano P, Bush JO.
    Dev Biol; 2015 Oct 15; 406(2):186-95. PubMed ID: 26385750
    [Abstract] [Full Text] [Related]

  • 10. The cytoplasmic domain of the ligand ephrinB2 is required for vascular morphogenesis but not cranial neural crest migration.
    Adams RH, Diella F, Hennig S, Helmbacher F, Deutsch U, Klein R.
    Cell; 2001 Jan 12; 104(1):57-69. PubMed ID: 11163240
    [Abstract] [Full Text] [Related]

  • 11. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.
    Füller T, Korff T, Kilian A, Dandekar G, Augustin HG.
    J Cell Sci; 2003 Jun 15; 116(Pt 12):2461-70. PubMed ID: 12734395
    [Abstract] [Full Text] [Related]

  • 12. Forward signaling by EphB1/EphB2 interacting with ephrin-B ligands at the optic chiasm is required to form the ipsilateral projection.
    Chenaux G, Henkemeyer M.
    Eur J Neurosci; 2011 Nov 15; 34(10):1620-33. PubMed ID: 22103419
    [Abstract] [Full Text] [Related]

  • 13. Evidence for a dual function of EphB4 as tumor promoter and suppressor regulated by the absence or presence of the ephrin-B2 ligand.
    Rutkowski R, Mertens-Walker I, Lisle JE, Herington AC, Stephenson SA.
    Int J Cancer; 2012 Sep 01; 131(5):E614-24. PubMed ID: 22161689
    [Abstract] [Full Text] [Related]

  • 14. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
    Wang Y, Nakayama M, Pitulescu ME, Schmidt TS, Bochenek ML, Sakakibara A, Adams S, Davy A, Deutsch U, Lüthi U, Barberis A, Benjamin LE, Mäkinen T, Nobes CD, Adams RH.
    Nature; 2010 May 27; 465(7297):483-6. PubMed ID: 20445537
    [Abstract] [Full Text] [Related]

  • 15. The critical role of the interplays of EphrinB2/EphB4 and VEGF in the induction of angiogenesis.
    Du E, Li X, He S, Li X, He S.
    Mol Biol Rep; 2020 Jun 27; 47(6):4681-4690. PubMed ID: 32488576
    [Abstract] [Full Text] [Related]

  • 16. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development.
    Gerety SS, Wang HU, Chen ZF, Anderson DJ.
    Mol Cell; 1999 Sep 27; 4(3):403-14. PubMed ID: 10518221
    [Abstract] [Full Text] [Related]

  • 17. Comparative analysis of embryonic gene expression defines potential interaction sites for Xenopus EphB4 receptors with ephrin-B ligands.
    Helbling PM, Saulnier DM, Robinson V, Christiansen JH, Wilkinson DG, Brändli AW.
    Dev Dyn; 1999 Dec 27; 216(4-5):361-73. PubMed ID: 10633856
    [Abstract] [Full Text] [Related]

  • 18. Generation of transgenic mice overexpressing EfnB2 in endothelial cells.
    Luxey M, Laussu J, Jungas T, Davy A.
    Genesis; 2011 Oct 27; 49(10):811-20. PubMed ID: 21735541
    [Abstract] [Full Text] [Related]

  • 19. Ligand-Dependent and Ligand-Independent Effects of Ephrin-B2-EphB4 Signaling in Melanoma Metastatic Spine Disease.
    Piffko A, Broggini T, Harms C, Adams RH, Vajkoczy P, Czabanka M.
    Int J Mol Sci; 2021 Jul 27; 22(15):. PubMed ID: 34360793
    [Abstract] [Full Text] [Related]

  • 20. Artery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis.
    Kim YH, Hu H, Guevara-Gallardo S, Lam MT, Fong SY, Wang RA.
    Development; 2008 Nov 27; 135(22):3755-64. PubMed ID: 18952909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.